Kurome Therapeutics, a preclinical stage company based in Cincinnati, OH, announced the closing of a $15 million Series A financing. The round was co-led by…
Houston, TX- based Stellanova Therapeutics announced the closing of a $15.5 million Series A financing led by Sporos Bioventures, LLC. Proceeds will support development of antibody…
Amyl Therapeutics has closed $22.3 million in Series A financing, led by Belgium-based Noshaq, with participation from Merieux Participations, Sambrinvest, and other private investors. Additionally,…
Cambridge, MA- based Kojin Therapeutics launched with a $60 million Series A led by Polaris Partners, Newpath Partners, and Cathay Health, affiliated to Cathay Capital.…
Has Advarra established the market’s leading network of registered trial sites focusing on gene therapy studies? Put more specifically, has the commercial institutional review board (IRB)-based…
With a race to enable virtual, decentralized, or remote clinical trials, a leading clinical trials services venture called Q2Solutions, the result of a joint venture…
Founded just in 2017, a new AI platform in the medical informatics space just raised an additional $18 million to fuel its growth and develop…
People in the U.S. and in some other countries are headed toward a “NASH” crisis, a not very well-known but pervasive disease associated with many…
Multinational pharmaceutical companies with local Korean divisions face unfortunate reductions in workforce due to the ongoing impacts of the pandemic as drug companies there actively…
With the acquisition of NeuroRX by Big Rock Partners, the newly formed public traded company NRx Pharmaceuticals (NRx) is traded under the ticker symbol “NRXP”…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
